Počki (Feb 2022)

An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International

  • Roman-Ulrich Müller,
  • A. Lianne Messchendorp,
  • Henrik Birn,
  • Giovambattista Capasso,
  • Emilie Cornec-Le Gall,
  • Olivier Devuyst,
  • Albertien van Eerde,
  • Patrick Guirchoun,
  • Tess Harris,
  • Ewout J. Hoorn,
  • Nine V.A.M. Knoers,
  • Uwe Korst,
  • Djalila Mekahli,
  • Yannick Le Meur,
  • Tom Nijenhuis,
  • Albert C.M. Ong,
  • John A. Sayer,
  • Franz Schaefer,
  • Aude Servais,
  • Vladimir Tesar,
  • Roser Torra,
  • Stephen B. Walsh and Ron T. Gansevoort

DOI
https://doi.org/10.22141/2307-1257.11.1.2022.357
Journal volume & issue
Vol. 11, no. 1
pp. 37 – 39

Abstract

Read online

No abstract